WASHINGTON (AP) - The Food and Drug Administration says Merck's cholesterol drug Vytorin helps reduce heart attack, stroke and related problems in patients with kidney disease, a potential new use for the blockbuster drug.
The agency's review also found no new safety concerns with Vytorin, which came under scrutiny...
more »